Welltower (NYSE: WELL) is one of 23 public companies in the “Healthcare REITs” industry, but how does it weigh in compared to its rivals? We will compare Welltower to related companies based on the strength of its analyst recommendations, institutional ownership, dividends, risk, profitability, earnings and valuation.
Welltower pays an annual dividend of $3.48 per share and has a dividend yield of 6.4%. Welltower pays out 274.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Healthcare REITs” companies pay a dividend yield of 6.3% and pay out 156.1% of their earnings in the form of a dividend.
86.1% of Welltower shares are owned by institutional investors. Comparatively, 83.8% of shares of all “Healthcare REITs” companies are owned by institutional investors. 0.2% of Welltower shares are owned by insiders. Comparatively, 6.5% of shares of all “Healthcare REITs” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Valuation & Earnings
This table compares Welltower and its rivals gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Welltower||$4.32 billion||$522.77 million||43.09|
|Welltower Competitors||$837.61 million||$168.57 million||171.44|
Welltower has higher revenue and earnings than its rivals. Welltower is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This is a breakdown of current recommendations and price targets for Welltower and its rivals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Welltower presently has a consensus target price of $65.69, suggesting a potential upside of 20.03%. As a group, “Healthcare REITs” companies have a potential upside of 13.33%. Given Welltower’s higher possible upside, equities analysts clearly believe Welltower is more favorable than its rivals.
This table compares Welltower and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Volatility and Risk
Welltower has a beta of 0.26, indicating that its share price is 74% less volatile than the S&P 500. Comparatively, Welltower’s rivals have a beta of -1.38, indicating that their average share price is 238% less volatile than the S&P 500.
Welltower rivals beat Welltower on 9 of the 15 factors compared.
Welltower Company Profile
Welltower Inc. invests with seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure. The Company invests in seniors housing and healthcare real estate. It operates in three segments: triple-net, seniors housing operating and outpatient medical. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities, and outpatient medical properties. Its triple-net properties include independent living facilities, independent supportive living facilities (Canada), continuing care retirement communities, assisted living facilities, care homes with and without nursing (the United Kingdom), Alzheimer’s/dementia care facilities, long-term/post-acute care facilities and hospitals. Its outpatient medical properties include outpatient medical buildings.
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.